Stage IV Melanoma: Clinical Trials

2 trials for Stage IV Melanoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Stage IV Melanoma: new trials by email Literature Review of Stage IV Melanoma trials Research Report on Stage IV Melanoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC), Autologous PBMCs in GM-CSF (MC) - Stage IV Melanoma, Stage III Melanoma
Phase 3TerminatedLisata Therapeutics, Inc.42014-10-012019-05-10
Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
allovectin-7, allovectin-7/dacarbazine, dacarbazine - Stage IV Melanoma, Stage III Melanoma
Phase 3CompletedVical1998-07-012008-07-25

Narrower conditions

Melanoma (2)  ·  Neoplasms (1)  ·  Skin Neoplasms (1)

Broader conditions

Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neuroectodermal Tumors (2)  ·  Neuroendocrine Tumors (2)  ·  Nevi and Melanomas (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Neoplasms (1)  ·  Skin Neoplasms (1)

Interventions

Allovectin-7 (1)  ·  Dacarbazine (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)

Sponsors

Lisata Therapeutics, Inc. (1)  ·  Vical (1)

Countries

United States (2)

Top investigators

Cherie Smith (1)  ·  Robert O Dillman, MD (1)

Results publications

PMID 26837440

NIH funding

2015 (1)